Skip to content

Now, let me examine the model carefully and provide a thorough review of the GO-CAM model "Pyruvate catabolic process 2 (Mouse)" (ID: gomodel:633b013300001469).

Review of GO-CAM Model: Pyruvate catabolic process 2 (Mouse)

Model Overview

This GO-CAM model represents the pyruvate catabolic process in mouse (NCBITaxon:10090), specifically focusing on the conversion of pyruvate to acetyl-CoA through the pyruvate dehydrogenase complex and associated transport mechanisms. The model has been updated to reflect current terminology, with automated changes replacing outdated GO terms (GO:0061732 with GO:0006086, and GO:0005967 with GO:0045254).

Model Structure and Biological Content

Pathway Coverage

The model captures the following key aspects of pyruvate catabolism: 1. Transport of pyruvate from the cytosol to mitochondrial matrix 2. Pyruvate dehydrogenase complex (PDC) activity and its components 3. Connection to acetyl-CoA biosynthesis

Molecular Components and Activities

The model includes several important proteins/complexes: - Voltage-dependent anion channel (VDAC1) - Facilitates transport across the outer mitochondrial membrane - Mitochondrial pyruvate carriers (MPC1, MPC2) - Transport pyruvate across the inner mitochondrial membrane - Pyruvate dehydrogenase complex components: - PDHA1/PDHA2/PDHB - Pyruvate decarboxylase activity - DLAT - Acetyltransferase activity - DLD - Dihydrolipoyl dehydrogenase activity - PDHX - Molecular adaptor activity within the complex

Strengths of the Model

  1. Comprehensive component representation: The model includes both transport mechanisms (VDAC1, MPC1, MPC2) and enzymatic activities (PDH complex components).

  2. Proper use of protein complexes: The model appropriately represents the pyruvate dehydrogenase complex (GO:0045254) with its constituent proteins and their specific activities.

  3. Cellular localization: Components are properly annotated with their cellular locations (mitochondrial outer membrane, inner membrane, or matrix).

  4. Evidence support: Annotations have appropriate evidence codes and literature references.

  5. Proper use of molecular adaptor activity: PDHX is correctly annotated with molecular adaptor activity (GO:0060090), consistent with its biological role of binding dihydrolipoamide dehydrogenase (E3) to dihydrolipoamide transacetylase (E2) within the PDH complex.

Areas for Improvement

  1. Redundant activities: There is some redundancy in the model. For example:
  2. Activities 633b013300001558 and 633b013300001625 both represent the same pyruvate dehydrogenase complex (GO:0045254) with the same components and molecular function (GO:0034604).
  3. Activities 633b013300001638 and 633b013300001646 both represent DLAT with the same acetyltransferase activity.

  4. Activities 633b013300001636 and 633b013300001648 both represent DLD with dihydrolipoyl dehydrogenase activity.

  5. Inconsistent causal associations: Some causal associations lack evidence annotations while others include them.

  6. Some causal flow clarity issues: The model would benefit from clearer representation of the exact sequence of events in the pyruvate dehydrogenase complex activity.

  7. Redundant molecular adaptor activity: PDHX is annotated twice with molecular adaptor activity (GO:0060090) in activities 66c7d41500001378 and 66c7d41500001379, which appear to be duplicates.

Specific Recommendations

  1. Consolidate redundant activities: Merge duplicate representations of the same protein or complex activities to make the model more concise and easier to follow.

  2. Add evidence to all causal associations: Ensure all causal associations have appropriate evidence annotations.

  3. Refine causal flow: Clarify the exact sequence of events in the pyruvate dehydrogenase complex activity, making sure the "provides input for" and "part of" relationships accurately reflect the biological process.

  4. Check complex membership annotations: Ensure the complex membership is consistent throughout the model and matches current knowledge about the pyruvate dehydrogenase complex in mice.

  5. Review recent literature: The paper "Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis" (PMID:31536960) mentions phosphorylation of PDHA2 on S291/S293 residues and its role in regulation. Consider incorporating this regulatory mechanism into the model if it applies to mouse as well.

Conclusion

Overall, this GO-CAM model provides a good representation of pyruvate catabolism in mouse, focusing on the pyruvate dehydrogenase complex and associated transport processes. The model adheres to GO-CAM best practices in terms of representing protein complexes and molecular activities. However, there are redundant activities that could be consolidated to make the model more streamlined. The causal flow could also be clarified to better represent the sequence of events in this metabolic pathway.

The model successfully captures the key molecular components involved in pyruvate catabolism, including the important adaptor role of PDHX in the pyruvate dehydrogenase complex, consistent with GO-CAM annotation guidelines for molecular adaptors.